CSIMarket Company Name, Ticker, Industry, else..
 
Poseida Therapeutics Inc   (NASDAQ: PSTX)
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 98
 Employees 330
 Revenues (TTM) (Millions $) 151
 Net Income (TTM) (Millions $) -61
 Cash Flow (TTM) (Millions $) 24
 Capital Exp. (TTM) (Millions $) 2

Business Description


Poseida Therapeutics Inc is a biotechnology company that focuses on developing gene therapies for the treatment of various diseases, including cancer and genetic disorders. The company's mission is to provide innovative and potentially curative treatments using its proprietary gene engineering platform, which enables precise and targeted genetic modifications. Poseida Therapeutics utilizes cutting-edge technology and expertise to develop and commercialize its gene therapies, with the aim of improving patient outcomes and quality of life. The company is committed to advancing the field of gene therapy through research and collaboration with other organizations.


   Company Address: 9390 Towne Centre Drive San Diego 92121 CA
   Company Phone Number: 779-3100   Stock Exchange / Ticker: NASDAQ PSTX


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
AMGN   -3.15%    
EXEL        0.16% 
GILD   -0.27%    
IMCR   -0.79%    
MRNA        1.04% 
NVAX        5.76% 
• View Complete Report
   



Announcement

Roche commences tender offer for all shares of Poseida Therapeutics, Inc. for $9.00 per share in cash, plus a non-tra...

Published Mon, Dec 9 2024 9:30 PM UTC

Roche s Strategic Acquisition: A Closer Look at Poseida Therapeutics Remarkable Performance Amid Tender OfferIn a significant move within the biopharmaceutical landscape, Roche Holding Ltd. has commenced a tender offer for Poseida Therapeutics, Inc. Following a previously announced merger agreement dated November 25, 2024, Roche is offering $9.00 in cash for each share of ...
Personnel Announcements

Poseida Therapeutics Employs Dr. Syed Rizvi, M.D., as Chief Medical Officer, Navigating Share Value Decline Amid Promising Cell and Gene Therapy Advancements.

Published Mon, Mar 25 2024 8:05 PM UTC

Poseida Therapeutics Appoints Syed Rizvi, M.D., as Chief Medical Officer; Shares Fall by 3.42% in a Challenging Market
SAN DIEGO, March 25, 2024 - Poseida Therapeutics, Inc. (Nasdaq: PSTX), a renowned clinical-stage cell and gene therapy company dedicated to revolutionizing treatments for cancer and rare diseases, has made a significant addition to its leadership team. T...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 3.2
Working Capital Ratio 3.47
Leverage Ratio (MRQ) 2.09
Total Debt to Equity 0.68
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.64 $
Revenues (TTM) 1.54 $
Cash Flow (TTM) 0.24 $
Cash 2.35 $
Book Value 0.89 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 457,145
Net Income per Employee (TTM) -184,118
Receivable Turnover Ratio (TTM) 12.52
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.57

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) 27.52 %
Net Margin (MRQ) 28.2 %
Net Cash Flow Margin (MRQ) 26.2 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.